Cytochroma's Series A Round

Cytochroma raised a round of funding on February 19, 1999. Investors include GeneChem Management.

Cytochroma is a clinical-stage specialty pharmaceutical company focused on developing and commercializing products to treat and prevent the clinical consequences of vitamin D insufficiency and SHPT as…

Articles about Cytochroma's Series A Round: